"What’s most important is that these models ensure equitable access to these treatments for any eligible patient. The tens of thousands of people with sickle cell should all have the same opportunity as Carter: to wake up one day and feel what it’s like to not be in pain. Equitable access is also what matters for the future of the technological revolution brewing in medicine. After all, what good are miracle cures if only the few can get them?"

https://www.bloomberg.com/opinion/features/2023-10-15/sickle-cell-gene-therapy-will-test-how-us-pays-for-million-dollar-cures?srnd=undefined